𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Biomarker discovery in lung cancer—promises and challenges of clinical proteomics

✍ Scribed by Ajit Bharti; Patrick C. Ma; Ravi Salgia

Publisher
John Wiley and Sons
Year
2007
Tongue
English
Weight
263 KB
Volume
26
Category
Article
ISSN
0277-7037

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Lung cancer is a devastating illness with an overall poor prognosis. To effectively address this disease, early detection and novel therapeutics are required. Early detection of lung cancer is challenging, in part because of the lack of adequate tumor biomarkers. The goal of this review is to summarize the knowledge of current biomarkers in lung cancer, with a focus on important serum biomarkers. The current knowledge on the known serum cytokines and tumor biomarkers of lung cancer will be presented. Emerging trends and new findings in the search for novel diagnostic and therapeutic tumor biomarkers using proteomics technologies and platforms are emphasized, including recent advances in mass spectrometry to facilitate tumor biomarker discovery program in lung cancer. It is our hope that validation of these new research platforms and technologies will result in improved early detection, prognostication, and finally the treatment of lung cancer with potential novel molecularly targeted therapeutics. © 2007 Wiley Periodicals, Inc., Mass Spec Rev

📜 SIMILAR VOLUMES

Global proteomics and metabolomics in ca
Global proteomics and metabolomics in cancer biomarker discovery
✍ Haleem J. Issaq; Stephen D. Fox; King C. Chan; Timothy D. Veenstra 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 166 KB

## Abstract Chromatography and electrophoresis have been used for the last half‐century to separate small and large molecules. Advances in MS instrumentation and techniques for sample introduction into the mass analyzer (i.e. matrix‐assisted laser desorption/ionization and electrospray ionization),

Mass spectrometry-based clinical proteom
Mass spectrometry-based clinical proteomics: Head-and-neck cancer biomarkers and drug-targets discovery
✍ Ajay Matta; Ranju Ralhan; Leroi V. DeSouza; K.W. Michael Siu 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 485 KB 👁 1 views

## Abstract Mass spectrometry (MS)‐based proteomics is a rapidly developing technology for both qualitative and quantitative analyses of proteins, and investigations into protein posttranslational modifications, subcellular localization, and interactions. Recent advancements in MS have made tremend

Cancer proteomics and its application to
Cancer proteomics and its application to discovery of therapy response markers in human cancer
✍ Laura Smith; Michael J. Lind; Kevin J. Welham; Lynn Cawkwell; Cancer Biology Pro 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 109 KB

## Abstract The administration of chemotherapy either alone or in combination with radiotherapy is an important factor in reducing the mortality and morbidity of cancer patients. Resistance to both chemotherapy and radiotherapy represents a major obstacle to a successful outcome. The identification

Predictors of enrollment in lung cancer
Predictors of enrollment in lung cancer clinical trials
✍ Wei Du; Shirish M. Gadgeel; Michael S. Simon 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB

## Abstract ## BACKGROUND Clinical trials may offer patients innovative therapeutic options with potentially better outcomes, which are particularly relevant for patients afflicted with lung carcinoma, because current therapies provide only modest survival benefits. Only approximately 5% of patien